Company News in the Life Science Industry

»

Reset 

Brickell Biotech Announces Approval of Sofpironium Bromide Gel, 5% in Japan for Treatment of Primary Axillary Hyperhidrosis Received by its Development Partner, Kaken Pharmaceutical

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Brickell Biotech, Inc.

Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  AxoGen, Inc.

Surrozen Expands Board of Directors with Appointment of David J. Woodhouse, Ph.D.

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Surrozen, Inc.

Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Todos Medical Ltd.

Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Catalyst Biosciences, Inc.

Graybug Appoints Three New Members to its Board of Directors

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Graybug Vision, Inc.

Cabaletta Bio to Present at Upcoming Investor Conferences in October

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Cabaletta Bio, Inc.

Collegium Appoints Rita Balice-Gordon to its Board of Directors

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Collegium Pharmaceutical, Inc.

Ultragenyx to Present at Jefferies Gene Therapy/Editing Summit

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Ultragenyx Pharmaceutical Inc.

Medexus Appoints Michael Pine as Senior Vice President of Business Development and Strategy

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Medexus Pharmaceuticals Inc.

Establishment Labs Finalizes Distribution Agreement with Puregraft LLC

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Establishment Labs S.A.

Generex Biotechnology Subsidiary NuGenHealth Contracts with Paradise Valley Family Medicine to Provide Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) Services

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Generex Biotechnology Corp. | Genovior Biotech Corporation

RespireRx Pharmaceuticals Inc. Announces Appointment of David Dickason as Senior Vice President Pre-Clinical Product Development

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  RespireRx Pharmaceuticals Inc.

Zomedica Announces Shareholder Meeting Voting Results

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Zomedica Pharmaceuticals Corp.

Press news Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 25 September 2020

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Biocartis NV

Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Galecto, Inc.

EUROPEAN  COMMISSION  GRANTS  MARKETING  AUTHORIZATION FOR JYSELECA® (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE ACTIVE  RHEUMATHOID  ARTHRITIS

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Galapagos NV

Einvestment Fund Allocates EUR22M to AI and Robotics Sector

LISBON, Portugal, Sept. 25, 2020 /PRNewswire/ -- Einvestment's fund has allocated EUR22M to the AI and Robotics sector. The Sustainable... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020

Nordic Nanovector ASA: Prospectus approved

OSLO, Norway, Sept. 25, 2020 /PRNewswire/ -- Reference is made to the stock exchange announcements on 23 September 2020 where Nordic Nanovector ASA (the "Company") announced that the Company had carried out a successful private placement raising gross proceeds of approximately NOK 231... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  Nanobiotix SA | Nanoco Technologies Ltd.   | Nordic Nanovector ASA

RemeGen Announces US FDA Has Granted Breakthrough Therapy Designation for Disitamab Vedotin (RC48) in Urothelial Cancer

YANTAI, China, Sept. 25, 2020 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen") today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for disitamab vedotin (RC48), a novel humanized anti-HER2 antibody drug conjugate (ADC), for the second-line... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  RemeGen, Ltd.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies